New location in Leiden, The Netherlands will serve as hub for European operations and production of QurAlis’ products for clinical trials through commercialization CAMBRIDGE, Mass., Jan. 3, 2024 /PRNewswire/ — QurAlis Corporation, a clinical-stage biotechnology company driving scientific…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.